Vyndamax for Cardiomyopathy of Transthyretin-Mediated Amyloidosis User Reviews
- Ano...
- May 7, 2025
"After 2 years of Vyndamax, my heart failure is advancing, probably at a slower pace than without it. I developed a nasty skin rash only over my legs and a few days later over my forearms, worse over the back of my knees and antecubital areas, maybe not related to this medication. It’s very hard to open the blister-packed capsules."
- Ano...
- Taken for 1 to 2 years
- April 23, 2025
"Taking Vyndamax on the recommendation of my cardiologist, however I have no idea if the medication is working as described and if so to what extent. I was not aware of an alternative medication until I saw an advertisement."
See also:
Tegsedi
Tegsedi (inotersen) is an RNA-targeting treatment that may be used to reduce the symptoms of ...
Vyndaqel
Vyndaqel (tafamidis meglumine) is a transthyretin stabilizer that may be given to reduce death or ...
Onpattro
Onpattro is used to treat polyneuropathy in adults with hereditary transthyretin-mediated ...
Wainua
Wainua (eplontersen) is used to treat polyneuropathy of hereditary transthyretin-mediated ...
Amvuttra
Amvuttra is used to treat polyneuropathy associated with hereditary transthyretin-mediated ...
Frequently asked questions
- What’s the difference between Vyndaqel and Vyndamax?
- How long does it take Vyndamax to work?
- How long does it take for Vyndaqel to start working?
- Ran...
- Taken for 1 to 6 months
- July 26, 2024
"I had lost a lot of weight. I am in my third month using the medication, seem to have a bigger, better appetite and have put on about 5 needed pounds in the last 3 weeks. Wondering if that is a positive effect of the medication?"
- Ano...
- Taken for 5 to 10 years
- May 26, 2025
"Excellent. No drug side effects. Biggest drawback to continuing is the cost, which I cannot afford if insurance proceeds with plan to discontinue coverage August 1."
Are you taking this medicine?
Your review helps others make informed decisions.More about Vyndamax (tafamidis)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (8)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: transthyretin stabilizers
- En español
"I am 77 years of age. I have been taking Vyndamax, 61 mg daily, for over 2 1/2 years. I haven't had any noticeable adverse side effects from the drug. I have not suffered any hospitalizations since beginning the drug. I had two ablation procedures to correct atrial fibrillation prior to the amyloidosis diagnosis confirmation and beginning to take Vyndamax. I am able to continue to exercise regularly and continue normal activities. Annual echocardiograms show mild heart failure but have not progressed abnormally. I am pleased with the impact of the Vyndamax on my general health and prognosis. Unfortunately, it does not slow the aging process."